Guaifenesin 200 mg/Phenylephrine Hydrochloride 5 mg per 5 mL | GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE

23:28 EDT 26th August 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Guaifenesin 200 mgPhenylephrine hydrochloride 5 mg

ExpectorantNasal Decongestant

Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus, drain bronchial tubes, and make coughs more productive. Temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies (allergic rhinitis). Temporarily relieves nasal stuffiness. Helps decongest sinus openings and passages; temporarily relieves sinus congestion and pressure.

Do not exceed recommended dosage. If nervousness, dizziness, or sleeplessness occurs, discontinue use and consult a doctor. If symptoms do not improve within 7 days or are accompanied by fever, consult a doctor.

A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache, consult a doctor.

Do not take this product for persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, or where cough is accompanied by excessive phlegm (mucus) unless directed by a doctor.

Do not take this product if you have heart disease, high blood pressure, thyroid disease, diabetes, or difficulty in urination due to enlargement of the prostate gland unless directed by a doctor.

Do not use if you are now takin g a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

ask a health professional before use.

In case of accidental overdose, seek professional assistance, or contact a Poison Control Center immediately.

Adults and children 12 years of age and over: 10 mL every 4 hours, not to exceed 6 doses in 24 hours. Children 6 to under 12 years of age: 5 mL every 4 hours, not to exceed 6 doses in 24 hours. Children 2 to under 6 years of age: 2.5 mL every 4 hours, not to exceed 6 doses in 24 hours. Children under 2 years of age: Consult a physician.

Store at 20°-25°C (68°-77°F).

aspartame, bittermask, citric acid, glycerin, ethyl maltol, methylparaben, potassium citrate, potassium sorbate, propylene glycol, propylparaben, purified water, FD&C red #40, strawberry cream flavor, and sucrose.

Call 1-866-934-6025

IMAGE label.jpg


River’s Edge Pharmaceuticals, LLC

Active Ingredients


Drugs and Medications [1418 Associated Drugs and Medications listed on BioPortfolio]

Phenylephrine guaifenesin [River's Edge Pharmaceuticals, LLC]

RE Phenylephrine 1.5 mg/Guaifenesin 20 mg Drops

Healthy accents tussin cf [DZA Brands LLC]

DZA Brands, LLC Tussin CF Drug Facts

Rx act tussin cf [H E B]

HEB Tussin CF Cough and Cold Drug Facts

Tussin cf [HyVee Inc]

Hy-Vee, Inc. Tussin CF Drug Facts

Leader tussin cf [Cardinal Health]

Cardinal Health Tussin CF Drug Facts

Clinical Trials [1349 Associated Clinical Trials listed on BioPortfolio]

Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers

This study will evaluate the safety of phenylephrine hydrochloride 10 mg + acetaminophen 500 mg + dimethindene maleate 1 mg compared to phenylephrine hydrocloride 10 mg alone in healthy vo...

Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(COMPLETED)

This is a randomized, two-way crossover, multicenter study evaluating the consumer preference of Phenylephrine Extended Release Tablets, 30 mg to be taken as one tablet every 12 hours, or ...

Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study

The objectives of this pivotal study are: 1. to evaluate bioavailability of an extended-release and immediate release Codeine Phosphate/Guaifenesin tablet at steady state following...

Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED)

This study will assess the food-effect bioavailability of an extended release formulation of phenylephrine HCl and its bioequivalence to the marketed immediate release phenylephrine HCl pr...

The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study

This is a 14-day, randomized, placebo-controlled, parallel group, masked clinical trial of oral guaifenesin for the therapy of Chronic Rhinitis in 36 children between the ages of 7 and 18 ...

PubMed Articles [279 Associated PubMed Articles listed on BioPortfolio]

Chemometrics resolution and quantification power evaluation: Application on pharmaceutical quaternary mixture of Paracetamol, Guaifenesin, Phenylephrine and p-aminophenol.

Three advanced chemmometric-assisted spectrophotometric methods namely; Concentration Residuals Augmented Classical Least Squares (CRACLS), Multivariate Curve Resolution-Alternating Least Squares (MCR...

Cardiovascular Adverse Effects of Phenylephrine Eyedrops: A Systematic Review and Meta-analysis.

Topical phenylephrine hydrochloride is routinely administered with few safety precautions, but evidence regarding its systemic safety to date is controversial. As even short-term variations in 24-hour...

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study.

Phenylephrine hydrochloride (PE HCl) is widely used for the treatment of nasal congestion, but efficacy at the 10-mg dose is not known for certain. The Food and Drug Administration has requested that ...

The Differential Pupillary Response to 2.5% Phenylephrine in Patients Taking Tamsulosin.

Purpose: To determine if a pharmacological test could be developed to determine iris dilator dysfunction in patients taking tamsulosin. Methods: Patients taking tamsulosin and controls were recruited ...

Pharmacokinetics, Safety, and Cardiovascular Tolerability of Phenylephrine HCl 10, 20, and 30 mg After a Single Oral Administration in Healthy Volunteers.

Phenylephrine HCl 10 mg has been used as a nasal decongestant for over 50 years, yet only limited pharmacokinetic and metabolic data are available. The purpose of this study was to evaluate single-d...


Relevant Topics

Latest News Clinical Trials Research Drugs Reports Corporate
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Latest News Clinical Trials Research Drugs Reports Corporate
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Drugs and Medication Quicklinks

Searches Linking to this Drug Record